Search Within

Bone Marrow Transplant

Formats
  1. Meeting Abstract (1531)
  2. Journal Article (1197)
  3. Review (75)
  4. Research Letter (48)
  5. Book Section (34)
  6. Guidelines (26)
  7. Editorial (24)
  8. Correspondence (18)
  9. Conference Paper (14)
  10. Book Whole (1)
  11. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (2969)
  2. Department of Medicine (2969)
  3. Hematologic Malignancies, Division of (2846)
  4. Survivorship Research (1387)
  5. GSK Faculty (931)
  6. CTCR Scholars (872)

More Groups

People
  1. Sergio Giralt (1067)
  2. Miguel-Angel Perales (942)
  3. Sean Devlin (469)
  4. Ann Jakubowski (458)
  5. Gunjan Shah (446)
  6. Heather Landau (435)

More People

Years
  1. 2025 (66)
  2. 2024 (212)
  3. 2023 (263)
  4. 2022 (201)
  5. 2021 (177)
  6. 2020 (208)

More Years

Publications
  1. Blood (887)
  2. Biology of Blood and Marrow Transplantation (516)
  3. Bone Marrow Transplantation (175)
  4. Journal of Clinical Oncology (127)
  5. Transplantation and Cellular Therapy (113)
  6. Blood Advances (94)

More Publications

Publishers
  1. American Society of Hematology (988)
  2. Elsevier Inc. (766)
  3. Nature Publishing Group (261)
  4. American Society of Clinical Oncology (130)
  5. Wiley Blackwell (66)
  6. Taylor & Francis Group (65)

More Publishers

Results (2969)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Killer immunoglobulin-like receptor ligand (KIR-lig) mismatched natural killer (NK) cell transfusions for multiple myeloma (MM)
    Meeting Abstract

    Shi, J.; Szmania, S.; Rosen, N.; Moreno, A.; Walker, R.; Dupont, B.; Hsu, K.; Baxter-Lowe, L. A.; Shaughnessy, J.; Barlogie, B.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Response to immunizations following allogeneic HCT with adjuvant rituximab therapy
    Meeting Abstract

    Pao, M.; Papadopoulos, E. B.; Boulad, F.; Castro-Malaspina, H.; Jakubowski, A.; Kernan, N. A.; Perales, M.; Prockop, S.; Ford, R.; Young, J. W.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Results of T cell depleted (TCD) myeloablative hematopoietic stem cell transplants (HSCT) in patients with hematologic malignancies >= 55 yrs of age
    Meeting Abstract

    Jakubowski, A. A.; Papadopoulos, E. B.; Castro-Malaspina, H. R.; Hsu, K.; Perales, M. A.; Van Den Brink, M.; Young, J. W.; O'Reilly, R. J.
    Blood (2005)

    Fulltext@MSK | Save
  • Fludarabine pharmacokinetics in nonmyeloablative hematopoietic cell transplantation (HCT): Association with engraftment and neurotoxicty
    Meeting Abstract

    Jacobson, P. A.; Rogosheske, J.; Green, K.; Brunstein, C.; Barker, J.; Miller, J.; Wagner, J.; McGlave, P.; Tan, Y.; Weisdoff, D.
    Blood (2005)

    Fulltext@MSK | Save
  • Oral bioavailability of mycophenolate mofetil in patients undergoing nonmyeloablative hematopoietic cell transplantation (HCT) is poor and highly variable
    Meeting Abstract

    Jacobson, P.; Kathleen, G.; Rogosheske, J.; Brunstein, C.; Barker, J.; Defor, T.; McGlave, P.; Weisdorf, D.
    Blood (2005)

    Fulltext@MSK | Save
  • Missing killer immunoglobulin-like receptor (KIR) ligand confers protection from relapse in recipients of unrelated hematopoietic cell transplantation (HCT) for AML
    Meeting Abstract

    Hsu, K. C.; Malkki, M.; Gooley, T. A.; Dupont, B.; Petersdorf, E. W.
    Biology of Blood and Marrow Transplantation (2005)

    Fulltext@MSK | Save
  • Lack of HLA-C group 2 KIR ligand in the recipient predictive of lower relapse and higher overall survival in unrelated transplants
    Meeting Abstract

    Hsu, K. C.; Malkki, M.; Gooley, T.; Pinto-Agnello, C.; Dupont, B.; Petersdorf, E.
    Tissue Antigens (2005)

    Fulltext@MSK | Save
  • Fludarabine-based conditioning secures engraftment of secondary hematopoietic stem cell allografts (HSCT) used to treat graft failure
    Meeting Abstract

    Chewning, J. H.; Castro-Malaspina, H. R.; Hsu, K.; Jakubowski, A. A.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M. A.; Prockop, S. E.; Small, T. N.; van den Brink, M. R. M.; more...
    Biology of Blood and Marrow Transplantation (2005)

    Fulltext@MSK | Save
  • Induction of remission prior to transplantation improves the disease-free survival (DFS) of patients with advanced myelodysplastic syndromes (MDS) treated with myeloablative T-cell depleted (TCD) stem cell transplants (SCT) from HLA identical siblings
    Meeting Abstract

    Castro-Malaspina, H. R.; Jakubowski, A. A.; Papadopoulos, E. B.; Boulad, F.; Young, J. W.; Kernan, N. A.; Perales, M. A.; Small, T. N.; Hsu, K. C.; Chiu, M.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Umbilical cord blood (UCB) transplantation for indolent lymphoid malignancies
    Meeting Abstract

    Barker, J. N.; Wagner, J. E.
    Biology of Blood and Marrow Transplantation (2005)

    Fulltext@MSK | Save